Moxetumomab Pasudotox-tdfk and Signifor (Pasireotide Injection)
Determining the interaction of Moxetumomab Pasudotox-tdfk and Signifor (Pasireotide Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Signifor Injection
- Moxetumomab Pasudotox-tdfk-Signifor LAR
- Moxetumomab Pasudotox-tdfk-Signifor LAR Injection
- Moxetumomab Pasudotox-tdfk-Siklos
- Moxetumomab Pasudotox-tdfk-Siladryl Allergy
- Moxetumomab Pasudotox-tdfk-Silalite Pak
- Signifor (Pasireotide Injection)-Moxetumomab pasudotox-tdfk Intravenous
- Signifor (Pasireotide Injection)-Moxifloxacin
- Signifor (Pasireotide Injection)-Moxifloxacin (Systemic)
- Signifor (Pasireotide Injection)-Moxifloxacin Hydrochloride
- Signifor (Pasireotide Injection)-Moxifloxacin Injection
- Signifor (Pasireotide Injection)-Moxifloxacin Intravenous